Newsfeeds Archive - Page 157 of 167

1 minute read

Pricesmart Q3 EPS $0.62 Misses $0.80 Estimate, Sales $1.03B Beat $951.87M Estimate

July 11, 4:02 PM

Pricesmart (NASDAQ:PSMT) reported quarterly earnings of $0.62 per share which missed the analyst consensus estimate of $0.80 by 22.5 percent. This is a 15.07 percent decrease over earnings of $0.73 per share from the

PSMT

1 minute read

Knightscope Receives New Contract From A REIT For Autonomous Security Robot Services; Terms Not Disclosed

By Bill Haddad

July 11, 1:40 PM

Public Safety Innovator Continues Market Expansion Knightscope, Inc. (NASDAQ:KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, today announced that it has

KSCP

1 minute read

News

US Said To Prepare To Extend COVID Health Emergency Friday

By Bill Haddad

July 11, 1:40 PM

-Reuterss

BNTX

1 minute read

Media
News

‘Netflix Interviewing Multiple External Candidates for New Senior Role Overseeing Ad-Supported Tier’ -WSJ Exclusive Article

By Bill Haddad

July 11, 1:32 PM

https://www.wsj.com/articles/netflix-interviewing-multiple-external-candidates-for-new-senior-role-overseeing-ad-supported-tier-11657558796?mod=e2tw

NFLX

1 minute read

Molecular Diagnostics To Be Granted US Patent titled ‘METHODS FOR SUBTYPING DIFFUSE LARGE B-CELL LYMPHOMA (AND USING THE RESULTS FOR DIAGNOSIS, PROGNOSIS, AND THERAPY SELECTION)’

By Bill Haddad

July 11, 1:29 PM

https://twitter.com/PatentGrants/status/1546546503556014080

HTGM

1 minute read

Missouri Health System Signs New Contract For Streamline Health eValuator; Terms Not Disclosed

By Bill Haddad

July 11, 8:30 AM

Not-for-Profit Organization Chooses Automated Pre-Bill Coding Analysis to Improve Financial Performance Atlanta, GA, July 11, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:STRM), a

STRM

3 minute read

Arcutis Biotherapeutics Announces Health Canada Accepts For Review New Drug Submission For Roflumilast Cream For Adults And Adolescents With Plaque Psoriasis

By Bill Haddad

July 11, 8:06 AM

Submission supported by positive clinical data from the pivotal Phase 3 DERMIS-1 and DERMIS-2 clinical studies, as well as results from long-term safety studies If approved, roflumilast cream would be the first and

ARQT

1 minute read

FDA Clears LPCN 2101 IND For Adult Epilepsy Treatment

By Bill Haddad

July 11, 8:00 AM

Lipocine Inc. (NASDAQ:LPCN), a biopharmaceutical company focused on developing innovative products to treat metabolic and central nervous system ("CNS") disorders with high unmet medical needs, announced

LPCN

4 minute read

Titan Machinery Acquires Heartland Ag Systems For $110M

By Bill Haddad

July 11, 7:34 AM

- Strategically provides Titan Machinery access to the Case IH full-line of application equipment products, enhancing competitiveness - - Drives significant value creation and incremental sales opportunities

TITN

1 minute read

Gol Linhas Sees Q2 Loss Per Share & Loss Per American Depositary Shares Of About R$1.801 And $0.751, Respectively

By Bill Haddad

July 11, 7:17 AM

-Reuters

GOL